New research links common artificial sweeteners to 62% faster cognitive decline in adults under 60.
Two FDA-approved Alzheimer's drugs, lecanemab and donanemab, are now being tested as an alzheimers prevention drug in people with no symptoms at
Neurologists warn the Ozempic ALS risk is real: semaglutide's weight-loss mechanism may accelerate disease progression in ALS patients.
A first-in-human brain cancer cell therapy trial at Children's National Hospital produced long-term survivors among children with DIPG
A 2026 MIT study published in Nature found the keto diet promotes small intestinal tumors while suppressing colon cancer
Cancer in young adults is rising sharply, and a 2026 Nature Medicine study links accelerated biological aging in millennials and Gen Z to
A 2026 JAMA Ophthalmology study found nicotinamide (vitamin B3) may help prevent vision loss by cutting glaucoma risk 66% in people with high
A 2026 Cedars-Sinai study of 354,957 people found coffee — including decaf — is linked to sharply lower risks of cirrhosis, liver cancer
Vitamin D research 2026 reveals 5 new findings linking deficiency to Alzheimer's tau, depression, H.
New 2026 studies reveal that cannabis and tobacco co-use is among the most significant schizophrenia risk factors identified in years
Podiatrists across the U.S. are warning GLP-1 users about "Ozempic feet" — painful foot changes caused by rapid fat pad loss.
New research in JAMA Network Open finds 1 in 3 older men experience no benefit from tamsulosin
